Clinical Trial

To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

Completed Phase 1
View on ClinicalTrials.gov →
Summary
A randomized, open-label, single dose, 2x2 crossover study to evaluate the safety and pharmacokinetic characteristics after administration of Epaminurad in healthy adult volunteers under fasting conditions
Protocol Amendment History 3 changes
critical Trial completed 2026-04-24
notable Primary completion moved earlier: 2026-04-19 -> 2026-02-19 2026-04-24
minor Completion moved earlier: 2026-04-19 -> 2026-02-24 2026-04-24
Trial Details
NCT Number NCT07374406
Lead Sponsor JW Pharmaceutical
Conditions Healthy
Enrollment 34 participants
Start Date 2026-02-02
Primary Completion 2026-02-19 (estimated)
Study Completion 2026-02-24 (estimated)
Updated on ClinicalTrials.gov 2026-08-13